Major Scope

  •  Cardiovascular Case Reports
  •  Oncology Case Reports
  •  Surgical Case Reports
  •  Gastroenterological Case Reports
  •  Neurological Case Reports
  •  Dermatological Case Reports
  •  Respiratory Case Reports
  •  Obstetrics/Gynecology Case Reports
  •  Nephrology Case Reports
  •  Immunology Case Reports
  •  Paediatric Case Reports
  •  Orthopedics Case Reports
  •  Dental Case Reports

Abstract

Citation: Clin Case Rep Int. 2023;7(1):1593.DOI: 10.25107/2638-4558.1593

Relyvrio – For the Treatment of Amyotrophic Lateral  Sclerosis

Areeba I and Areeba I
 

Dow University of Health Sciences, Baba-E-Urdu Road, Pakistan
Karachi Medical and Dental College (KMDC) Block M, Pakistan

*Correspondance to: Areeba Ikram 

 PDF  Full Text Short Communication | Open Access

Abstract:

#

Keywords:

Drugs; Relyvrio; Amyotrophic lateral sclerosis; ALS; Lou Gehrig’s disease; FDA

Cite the Article:

Areeba I, Areeba I. Relyvrio – For the Treatment of Amyotrophic Lateral Sclerosis. Clin Case Rep Int. 2023; 7: 1593.

Journal Basic Info

  • Impact Factor: 4.082**
  • H-Index: 6
  • ISSN: 2638-4558
  • DOI: 10.25107/2638-4558

Search Our Journal

Journal Indexed In

Articles with Grants

Clinicopathological Characteristics of Medullary Thyroid Carcinoma with the Expression of Thyroglobulin in East – China
 Abstract  PDF  Full Text
Transient ST-Segment Elevation in the Context of MINOCA: A Case Report
 Abstract  PDF  Full Text
View More...